We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$826M
AUM Growth
Cap. Flow
+$577M
Cap. Flow %
69.85%
Top 10 Hldgs %
23.05%
Holding
4,682
New
4,618
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33M
2
AAPL icon
Apple
AAPL
+$32.5M
3
BKNG icon
Booking.com
BKNG
+$28.7M
4
AMZN icon
Amazon
AMZN
+$25.7M
5
BIDU icon
Baidu
BIDU
+$16.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.8%
2 Technology 11.13%
3 Healthcare 8.34%
4 Energy 5.42%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADXS
2051
DELISTED
Advaxis Inc
ADXS
$18K ﹤0.01%
+153
New +$8.6K
LORL
2052
CALL
DELISTED
Loral Space and Communications, Inc.
LORL
$18K ﹤0.01%
+189
New +$14.2K
CRZO
2053
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
$18K ﹤0.01%
+192
New +$8.63K
ARIA
2054
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$18K ﹤0.01%
+74
New +$463
ORIG
2055
PUT
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
0
KRFT
2056
PUT
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$18K ﹤0.01%
+109
New +$6.38K
PT
2057
DELISTED
PORTUGAL TELECOM SGPS, S.A.
PT
$18K ﹤0.01%
+16,800
New +$26.3K
NWBO
2058
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$18K ﹤0.01%
+3,324
New +$17K
ABUS icon
2059
PUT
Arbutus Biopharma
ABUS
$865M
$17K ﹤0.01%
+87
New +$1.5K
ASML icon
2060
PUT
ASML
ASML
$675B
$17K ﹤0.01%
+155
New +$15.7K
BTI icon
2061
PUT
British American Tobacco
BTI
$132B
$17K ﹤0.01%
+26
New +$1.46K
CHEF icon
2062
CALL
Chefs' Warehouse
CHEF
$3.87B
$17K ﹤0.01%
+13
New +$229
CSCO icon
2063
PUT
Cisco
CSCO
$450B
$17K ﹤0.01%
+394
New +$10.2K
DHI icon
2064
CALL
D.R. Horton
DHI
$41B
$17K ﹤0.01%
+101
New +$2.36K
DLR icon
2065
PUT
Digital Realty Trust
DLR
$73.7B
$17K ﹤0.01%
+63
New +$4.21K
GRFS
2066
PUT
Grifois
GRFS
$5.16B
$17K ﹤0.01%
+70
New +$1.21K
GSK icon
2067
CALL
GSK
GSK
$103B
$17K ﹤0.01%
+252
New +$14.1K
JKS
2068
JinkoSolar
JKS
$775M
$17K ﹤0.01%
+856
New +$19.1K
KBH icon
2069
CALL
KB Home
KBH
$3.48B
$17K ﹤0.01%
+95
New +$1.53K
MAC icon
2070
Macerich
MAC
$7.32B
$17K ﹤0.01%
+206
New +$15.2K
NCLH icon
2071
CALL
Norwegian Cruise Line
NCLH
$8.89B
$17K ﹤0.01%
+69
New +$2.77K
TCPC icon
2072
BlackRock TCP Capital
TCPC
$265M
$17K ﹤0.01%
+1,002
New +$16.4K
THO icon
2073
Thor Industries
THO
$3.99B
$17K ﹤0.01%
+299
New +$16.1K
TRP icon
2074
PUT
TC Energy
TRP
$73.5B
$17K ﹤0.01%
+49
New +$2.38K
UNFI icon
2075
CALL
United Natural Foods
UNFI
$3.01B
$17K ﹤0.01%
+36
New +$2.54K

Similar funds

Simplex Trading's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Simplex Trading, which disclosed 4,682 positions worth $826M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Gilead Sciences: 319,426 shares worth $30.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Technology and Healthcare.

  • Simplex Trading's largest Q4 2014 buy was Gilead Sciences: 319,426 shares worth $30.1M.
  • Simplex Trading's ten largest holdings make up 23% of its $826M portfolio in Q4 2014.
  • Simplex Trading disclosed 4,682 positions in Q4 2014, its first 13F filing on record.

Based on Simplex Trading's 13F filing for Q4 2014, filed 4 Mar 2015.